drugset / Trial / NCT02126670
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-09
- Completion
- 2014-09
Outcome
Missed primary endpoint
registry ACT01 Plus Comp01 vs ACT01 Plus Comp02 vs ACT01 Plus Comp03 vs ACT01 Plus Comp04; p = 0.799; Chi-squared NCT02126670 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACT01 | Unknown | — | — |
| Comparator | Comp02 | Unknown | — | — |
| Comparator | Comp03 | Unknown | — | — |
| Subject | Comp04 | Unknown | — | — |